Search hospitals > Ohio > Canton
Neuro-Behavioral Clinical Research, Inc
Claim this profileCanton, Ohio 44718
Global Leader in Depression
Global Leader in Major Depressive Disorder
Conducts research for Schizophrenia
Conducts research for Alzheimer's Disease
Conducts research for Migraine
95 reported clinical trials
1 medical researcher
Summary
Neuro-Behavioral Clinical Research, Inc is a medical facility located in Canton, Ohio. This center is recognized for care of Depression, Major Depressive Disorder, Schizophrenia, Alzheimer's Disease, Migraine and other specialties. Neuro-Behavioral Clinical Research, Inc is involved with conducting 95 clinical trials across 49 conditions. There are 1 research doctors associated with this hospital, such as Shishuka Malhotra, MD.Area of expertise
1Depression
Global LeaderMGH-ATRQ
Selective Serotonin Reuptake Inhibitors (SSRI)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
2Major Depressive Disorder
Global LeaderMGH-ATRQ
Selective Serotonin Reuptake Inhibitors (SSRI)
Serotonin-Norepinephrine Reuptake Inhibitors (SNRI)
Top PIs
Clinical Trials running at Neuro-Behavioral Clinical Research, Inc
Depression
Schizophrenia
Adolescent Health
Pediatric Migraine
Bipolar Depression
Obsessive-Compulsive Disorder
Major Depressive Disorder
Sickle Cell Anemia
Sickle Cell Disease
Alzheimer's Disease
Investigational Drug
for Bipolar Depression
A clinical trial to study the efficacy and safety of an investigational drug in people with major depressive episodes associated with with Bipolar I disorder (bipolar I depression) Participants in the study will either receive the drug being studied or a placebo. The study will be conducted in approximately 90 sites in North America, Europe, Latin America and Japan. It will be have both male and female participants ages 18-65. Participation in the study will be approximately 10 weeks.
Recruiting1 award Phase 35 criteria
BI 1569912
for Depression
This study is open to adults between 18 and 65 with a type of depression (major depressive disorder) for whom previous treatments for depression did not work. The purpose of the study is to find out whether a medicine called BI 1569912 helps people with depression. Participants continue their standard therapy throughout the study. Participants are put into 4 groups by chance. 3 of the 4 groups take different doses of BI 1569912. 1 group takes placebo. Placebo tablets looks like BI 1569912 but do not contain any medicine. Participants take the tablets once a day for 6 weeks. Participants are in the study for about 2 to 4 and a half months. During this time, they visit the study site at least 6 times. At the visits, doctors ask participants about their symptoms. The participants answer questions about their depression symptoms. The results are compared between the groups. The doctors also regularly check the general health of participants.
Recruiting0 awards Phase 23 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Neuro-Behavioral Clinical Research, Inc?
Neuro-Behavioral Clinical Research, Inc is a medical facility located in Canton, Ohio. This center is recognized for care of Depression, Major Depressive Disorder, Schizophrenia, Alzheimer's Disease, Migraine and other specialties. Neuro-Behavioral Clinical Research, Inc is involved with conducting 95 clinical trials across 49 conditions. There are 1 research doctors associated with this hospital, such as Shishuka Malhotra, MD.